Revised Two-Stage Model of Preeclampsia Based on Autophagic Dysfunction: A Comprehensive Review
Biomolecules · 2026
DOI: 10.3390/biom16030441 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Atsushi Furuta und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Toyama, Toyama 930-0194, Japan. Hauptthemen laut MEDLINE: Pre-Eclampsia, Autophagy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, NICHD NIH HHS, JSPS KAKENHI.
Abstract (Originalsprache)
A revised two-stage model of preeclampsia is proposed, centering on an autophagy-dependent requirement for extravillous trophoblast entry into the proximal one-third of the myometrium. The One-Third Myometrium Enigma, introduced here, denotes the unresolved physiological rule that early placentation requires trophoblasts to traverse decidua and reach the proximal one-third of myometrium under hypoxia and nutrient scarcity. The hypothesis posits a timed rise in basal autophagy to sustain trophoblast energy homeostasis and invasion, accompanied by TFEB-driven lysosomal programs that enable villous cytotrophoblast syncytialization. Autophagic dysfunction could contribute to shallow invasion, chronic placental hypoxia, fetal growth restriction, and release of placental injury signals preceding maternal syndrome. Potential failure modes include reduced autophagic flux due to inhibition of autophagosome to lysosome fusion or mistimed persistence of hypoxia signaling, such as prolonged HIF-1α activity. Collectively, this evidence suggests that impaired autophagy is a testable contributor to preeclampsia pathogenesis. Predictions include early risk stratification with circulating autophagy markers and extracellular vesicle microRNAs, and therapeutic benefit from autophagy modulation that targets AMPK or mTOR or activates TFEB with safety constraints. This framework reframes preeclampsia as a disorder of placental quality control and specifies where and when autophagy may be required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Toyama, Toyama 930-0194, Japan.
- Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
- Departments of Obstetrics and Gynecology and Pediatrics, University of Texas Medical Branch, Galveston, TX 77555, USA.
ORCID-Profile: Shina Sakaguchi, Shibin Cheng, Akitoshi Nakashima
Förderung
- Japan Society for the Promotion of Science
- NICHD NIH HHS
- JSPS KAKENHI
- NIH
Zitieren
APA
Furuta, A., Shima, T., Nishigori, T., Yamada, K., Nunomura, H., Yoshida, M., Sakaguchi, S., Majima, T., Yamaki-Ushijima, A., Shozu, K., Tsuda, S., Cheng, S., Sharma, S., & Nakashima, A. (2026). Revised Two-Stage Model of Preeclampsia Based on Autophagic Dysfunction: A Comprehensive Review. Biomolecules. https://doi.org/10.3390/biom16030441
Vancouver
Furuta A, Shima T, Nishigori T, Yamada K, Nunomura H, Yoshida M, et al. Revised Two-Stage Model of Preeclampsia Based on Autophagic Dysfunction: A Comprehensive Review. Biomolecules. 2026. doi:10.3390/biom16030441
BibTeX
@article{Furuta2026,
author = {Furuta, Atsushi and Shima, Tomoko and Nishigori, Takashi and Yamada, Kiyotaka and Nunomura, Haruka and Yoshida, Mihoko and Sakaguchi, Shina and Majima, Takuya and Yamaki-Ushijima, Akemi and Shozu, Kanto and Tsuda, Sayaka and Cheng, Shibin and Sharma, Surendra and Nakashima, Akitoshi},
title = {Revised Two-Stage Model of Preeclampsia Based on Autophagic Dysfunction: A Comprehensive Review},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16030441}
}
EUVIMED